In support of our results, a number of studies have demonstrated a tumour suppressive role of NCOR2 in cancers, such as LUAD, head and neck squamous cell carcinoma, non-Hodgkin lymphoma and osteosarcoma14–17. Here, NCOR2 is linked to head and neck squamous cell carcinoma.